Faculty

Aruna Kamineni

Clinical Assistant Professor, Epidemiology

206-287-2922
Aruna.S.Kamineni@kp.org

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Washington, 1997

Contact

206-287-2922
Aruna.S.Kamineni@kp.org

WA
View Website »

Bio

Aruna Kamineni, PhD, MPH, began her research at Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.

Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.

Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.

Recent Publications (PubMed)

Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review.
(2023 Feb 8)
J Natl Cancer Inst
Selby K, Sedki M, Levine E, Kamineni A, Green BB, Vachani A, Haas JS, Ritzwoller DP, Croswell JM, Ohikere K, Doria-Rose VP, Rendle KA, Chubak J, Lafata JE, Inadomi J, Corley DA

Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.
(2023 Apr 1)
J Low Genit Tract Dis 27(2): 113-119
Del Vecchio NJ, Beaber EF, Garcia MP, Wheeler CM, Kamineni A, Chao C, Chubak J, Corley DA, Owens CL, Winer RL, Pruitt SL, Raine-Bennett T, Feldman S, Silverberg M

Provider beliefs in effectiveness and recommendations for primary HPV testing inĀ 3 health-care systems.
(2023 Jan 3)
JNCI Cancer Spectr 7(1):
Kruse GR, Lykken JM, Kim EJ, Haas JS, Higashi RT, Atlas SJ, McCarthy AM, Tiro JA, Silver MI, Skinner CS, Kamineni A

Factors associated with timely colposcopy following an abnormal cervical cancer test result.
(2022 Nov)
Prev Med 164(): 107307
Feldman S, Lykken JM, Haas JS, Werner CL, Kobrin SC, Tiro JA, Chubak J, Kamineni A

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.
(2022 Nov)
Ann Intern Med 175(11): 1582-1590
Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Elston Lafata J, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN

Show complete publication list

In the News

No news articles at this time.